Remgro’s Mediclinic deal raises concentration risk … but may be worth it

Analysis of Remgro moving ahead with its Mediclinic restructuring and why more than 60% of consumers are running out of money before month-end.

#Remgros #Mediclinic #deal #raises #concentration #risk #worth

Leave a Reply

Your email address will not be published. Required fields are marked *